ISIDORe

**Our mission** Increasing European and global capacity to prevent and respond to infectious threats. The ISIDORe project assembles the largest and most diverse research and service-providing instrument to study infectious diseases in Europe, with expertise from structural biology to clinical trials. By giving scientists access to the whole extent of our state-of-the-art facilities, cutting-edge services, advanced equipment and expertise, in an integrated way and with a common goal, we will accelerate the generation of new knowledge and intervention tools **to enhance Europe’s capacity for controlling (re)emerging and epidemic infectious diseases, starting with the COVID-19 pandemic**. **WHAT WE DO** ISIDORe supports scientists and their research on epidemic- and pandemic-prone pathogens, the development of medical countermeasures, with the aim of increasing resilience in the face of epidemics in Europe and globally. Free transnational access to research resources, services and expertise We provide free transnational access to a comprehensive portfolio of high-quality [services](https://isidore-project.eu/services/) that support user projects. See the full catalogue of services [here.](https://isidore-project.eu/services/) Transnational access (TNA) calls for proposals The provision of research services to researchers is organised through calls for proposals and the selection of research projects to access ISIDORe resources for free. Learn about [Transnational Access](https://isidore-project.eu/calls/) and see our open [calls](https://isidore-project.eu/calls/) for proposals. Development of new services We conduct research activities with an immediate impact on the quality, diversity and relevance of [our services](https://isidore-project.eu/services/) to offer the most advanced, innovative and cutting-edge catalogue of services possible. You did not find the service you need in our catalogue? Please let us know by filling out the [dedicated form](https://isidore-project.eu/services#gform_wrapper_14). ISIDORe has received funding from the European Union’s Horizon Europe research and innovation programme under grant agreement number 101046133.